Journalist Hunt

JournalistsPricingBlogs
LoginSign up

Teru Hideshima - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Teru Hideshima's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Teru Hideshima

Teru Hideshima

Verified

Editorial Board, Blood Cancer Journal

Beats

Primary beats

ScienceHealth

Secondary beats

Luxury goods and servicesWellnessRebellions and uprisingsRelationshipsSoccerMental HealthHealthcareTravel and tourismAgingFeaturesGlobal TradeAirports

Final Covers

Technology, Health Care, Entertainment , Mental Health , Alzheimer’s , Dementia, Automotive

Doesn’t Cover

I don't cover politics, tech and gaming.

Journalist Type

Editor

Seniority Positions

Editorial Board

Industries

-

Medium Formats

Blood Cancer Journal

Content

Total articles 4

  • Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma - Leukemia

    By Jooeun Bae, Teru Hideshima, Yu-Tzu Tai, Fabrizio Accardi

    Jul. 21, 2021

  • ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment

    By Jiye Liu, Teru Hideshima, Lijie Xing, Su Wang

    Jun. 04, 2021

  • Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma - Leukemia

    By Jooeun Bae, Teru Hideshima, Yu-Tzu Tai, Fabrizio Accardi

    Jul. 21, 2021

As seen in

Blood Cancer Journal,Nature,Science Magazine

Company Info

Blood Cancer Journal

Hoboken, New Jersey, United States

'+1 201-748-6000

Founded: